BRIEF-Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process

Reuters11-24

BRIEF-<a href="https://laohu8.com/S/CLSD">Clearside Biomedical</a> To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process

Nov 24 (Reuters) - Clearside Biomedical Inc CLSD.O:

CLEARSIDE BIOMEDICAL TO PURSUE STRATEGIC SALE OF ITS BUSINESS THROUGH VOLUNTARY CHAPTER 11 PROCESS
CLEARSIDE BIOMEDICAL INC - FILES FOR CHAPTER 11 BANKRUPTCY
CLEARSIDE BIOMEDICAL INC - SEEKS AUTHORIZATION FOR AUCTION AND SALE PROCESS

Source text: ID:nGNX5vjW87

Further company coverage: CLSD.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2585467348?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-24 21:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2585467348","market":"nz","top_or_hot":-1,"title":"BRIEF-Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CLSD\">Clearside Biomedical</a> To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process</title></head><body><p><span>Nov 24 (Reuters)</span><span> - </span>Clearside Biomedical Inc <span>CLSD.O</span>:</p><ul><li><p>CLEARSIDE BIOMEDICAL TO PURSUE STRATEGIC SALE OF ITS BUSINESS THROUGH VOLUNTARY CHAPTER 11 PROCESS</p></li><li><p>CLEARSIDE BIOMEDICAL INC - FILES FOR CHAPTER 11 BANKRUPTCY</p></li><li><p>CLEARSIDE BIOMEDICAL INC - SEEKS AUTHORIZATION FOR AUCTION AND SALE PROCESS</p></li></ul><p>Source text: <span>ID:nGNX5vjW87</span></p><p>Further company coverage: <span>CLSD.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-24 21:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CLSD\">Clearside Biomedical</a> To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process</title></head><body><p><span>Nov 24 (Reuters)</span><span> - </span>Clearside Biomedical Inc <span>CLSD.O</span>:</p><ul><li><p>CLEARSIDE BIOMEDICAL TO PURSUE STRATEGIC SALE OF ITS BUSINESS THROUGH VOLUNTARY CHAPTER 11 PROCESS</p></li><li><p>CLEARSIDE BIOMEDICAL INC - FILES FOR CHAPTER 11 BANKRUPTCY</p></li><li><p>CLEARSIDE BIOMEDICAL INC - SEEKS AUTHORIZATION FOR AUCTION AND SALE PROCESS</p></li></ul><p>Source text: <span>ID:nGNX5vjW87</span></p><p>Further company coverage: <span>CLSD.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLSD","symbol_name":"Clearside Biomedical Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nTUA9JDKRZ:1","article_id":"2585467348","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2585467348","pubTimestamp":1763990844,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 ProcessNov 24 (Reuters) - Clearside Biomedical Inc CLSD.O:CLEARSIDE BIOMEDICAL TO PURSUE STRATEGIC SALE OF ITS BU","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLSD":"Clearside Biomedical Inc.","CLSDQ":"Clearside Biomedical, Inc.","BK4007":"制药"},"translate_title":"简介-Clearside Biomedical将通过自愿的第11章程序出售其业务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLSD":0.9,"CLSDQ":0.9},"content_text":"BRIEF-Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 ProcessNov 24 (Reuters) - Clearside Biomedical Inc CLSD.O:CLEARSIDE BIOMEDICAL TO PURSUE STRATEGIC SALE OF ITS BUSINESS THROUGH VOLUNTARY CHAPTER 11 PROCESSCLEARSIDE BIOMEDICAL INC - FILES FOR CHAPTER 11 BANKRUPTCYCLEARSIDE BIOMEDICAL INC - SEEKS AUTHORIZATION FOR AUCTION AND SALE PROCESSSource text: ID:nGNX5vjW87Further company coverage: CLSD.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"event","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2585467348","isCrawlerRequest":true}